Anticholinergic agents

Anticholinergic agents has been studied in 8 papers since 2023: 8 observational studies in people; 3 in the past year. The newest story, Oct 4, 2026: “Anticholinergics link to higher dementia risk in older women”.

Intervention

8 papers study it14 findingsUpdated

See all 8 papers on anticholinergic agents

At a glance

Independent labs found the same change in people. 7 independent labs in 7 countries.

“Late (OR 1.49, 95% CI 1.25-1.79), transient (1.66, 1.28-2.14) and continuous (1.67, 1.22-2.29) exposure were significantly associated with increased recurrent falls compared with no exposure.”
Changes in anticholinergic cognitive burden and risk of single and recurrent falls: population-based cohort studyAge and ageing2025doi:10.1093/ageing/afaf177

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 7 independent labs in 7 countries
  • Funders: Italian Government Ministry of Health and others
  • Humans8

What did studies of anticholinergic agents find?

2

Studies of anticholinergic agents measured 2 outcomes: electronic frailty index and long-term care needs.

Electronic frailty index

no changein humans1

1 study
  1. Anticholinergic agents were not clearly linked with electronic frailty index in humans (compared with β3-agonist use in overactive bladder).

    Humanscompared with β3-agonist use in overactive bladder5 yearsfemales

    Anticholinergics link to higher dementia risk in older women

    International journal of urology : official journal of the Japanese Urological Association

More on Electronic frailty index

Long-term care needs

no changein humans1HR 1.03

1 study
  1. Anticholinergic agents were not clearly linked with long-term care needs in humans (compared with β3-agonist use in overactive bladder) (HR 1.03, 95% CI 0.87-1.22).

    Humanscompared with β3-agonist use in overactive bladderfemales

    Anticholinergics link to higher dementia risk in older women

    International journal of urology : official journal of the Japanese Urological Association

What is anticholinergic agents linked with?

11

Studies link anticholinergic agents with 11 measures, among them falls, dementia and cognitive impairment.

Falls

upin humans2OR 1.49

2 studies
  1. Anticholinergic agents are associated with falls in humans.

    Humans

  2. Anticholinergic agents are linked with a higher risk of falls in humans (late exposure compared with no exposure) (OR 1.49, 95% CI 1.25-1.79).

    Humanslate exposure compared with no exposuren = 10,717

Dementia

upin humans1HR 1.49

1 study
  1. Anticholinergic agents are linked with a higher risk of dementia in humans (compared with β3-agonist use in overactive bladder) (HR 1.49, 95% CI 1.04-2.13).

    Humanscompared with β3-agonist use in overactive bladderfemales

    Anticholinergics link to higher dementia risk in older women

    International journal of urology : official journal of the Japanese Urological Association

More on Dementia

Cognitive impairment

upin humans1OR 3.63

1 study
  1. Anticholinergic agents are associated with cognitive impairment in frail individuals with orthostatic hypotension (ACB ≥1) (OR 3.63, 95% CI 1.63-8.07).

    Humansin frail individuals with orthostatic hypotension (ACB ≥1)

More on Cognitive impairment

Accidental falls

upin humans1OR 2.39

1 study
  1. Anticholinergic agents are associated with accidental falls in frail individuals with orthostatic hypotension (ACB ≥1) (OR 2.39, 95% CI 1.13-5.05).

    Humansin frail individuals with orthostatic hypotension (ACB ≥1)

More on Accidental falls

Dependency

upin humans1OR 3.5

1 study
  1. Anticholinergic agents are associated with dependency in prefrail individuals with orthostatic hypotension (ACB ≥1) (OR 3.50, 95% CI 1.30-9.41).

    Humansin prefrail individuals with orthostatic hypotension (ACB ≥1)

Visual and verbal memory

downin humans1

1 study
  1. Anticholinergic agents are associated with visual and verbal memory in interaction with defined daily dose in older-age bipolar disorder.

    Humansin interaction with defined daily dose in older-age bipolar disordern = 121

More on Visual and verbal memory

Mortality

upin humans1HR 1.93

1 study
  1. Anticholinergic agents are linked with a higher risk of mortality in humans (CALS ≥ 2) (HR 1.93, 95% CI 1.07-3.46).

    HumansCALS ≥ 23-yearn = 600

Physical disability

upin humans1

1 study
  1. Anticholinergic agents are associated with physical disability in humans.

    Humansn = 600

Cognitive impairment

upin humans1OR 1.84

1 study
  1. Anticholinergic agents are associated with cognitive impairment in humans (CALS ≥ 2) (OR 1.84, 95% CI 1.02-3.34).

    HumansCALS ≥ 2n = 600

Frailty

upin humans1OR 2.26

1 study
  1. Anticholinergic agents are associated with frailty in humans (people with HIV, two or more ACMs vs non-users) (OR 2.26, 95% CI 1.09-4.70).

    Humanspeople with HIV, two or more ACMs vs non-userstwo or more ACMs

All 11

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 1Sep 2026: 0Oct 2026: 1Nov 2026: 03 papers in 12 months
International Journal of Urology

Anticholinergics link to higher dementia risk in older women

Anticholinergic use was associated with higher incident dementia risk compared with β3-agonist use (hazard ratio, 1.49; 95% CI, 1.04–2.13).Anticholinergic use was associated with higher incident dementia risk compared with β3-agonist use (hazard ratio, 1.49; 95% CI, 1.04–2.13).

Cohort study of 2,189 peopleDementia